Evaluating MAPT p.A152T as a risk factor for the 3R tauopathy Pick’s disease
Clicks: 1
ID: 320229
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #107 of 113 articles by views in Brain communications
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Genetic studies have significantly advanced our understanding of tauopathies, yet the genetic etiology of Pick’s disease, a rare 3-Repeat tauopathy, remains unclear. The MAPT p.A152T variant has been identified as a risk factor for Alzheimer’s disease and progressive supranuclear palsy, but its role in Pick’s disease is unknown. In this study, we examined the prevalence of MAPT p.A152T in the largest series of neuropathologically confirmed Pick’s disease cases to date (n=401). Through genotyping, we identified a single mutation carrier in the Pick’s disease cohort (Minor Allele Frequency = 0.12%). We previously reported MAPT p.A152T at a 0.20% frequency in healthy controls (n=2,456), suggesting it does not associate with 3-Repeat tauopathy risk. To further investigate the effect of the variant on MAPT transcript expression, we used bulk RNA sequencing in Alzheimer’s disease and progressive supranuclear palsy A152T mutation carriers. We did not detect significant differences in 4-Repeat tau levels, though preliminary trends may indicate more nuanced effects that need to be examined with long-read sequencing in a larger series. Overall, our study suggests that MAPT p.A152T does not increase Pick’s disease risk and may instead be linked to 4-Repeat or mixed tau pathologies, warranting further functional investigation.
| Reference Key |
openalex_W7167788418
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Nicole Tamvaka, William J. Scotton, Meredith T. Lilley, Maryam Shoai, Marios Gavrielatos, M HECKMAN, Alexandra I. Soto‐Beasley, Shanu F Roemer, Matthew C Baker, Rosa Rademakers, Melissa E. Murray, Dennis W. Dickson, John Hardy, Casey Cook, Jonathan D. Rohrer, Owen A. Ross, Rebecca R. Valentino, Tammaryn Lashley, Hannah Macpherson, Thomas T. Warner, Zane Jaunmuktane, Alejandro Martínez-Carrasco, Kin Mok, Tamas Revesz, Elizabeth Christopher, Michael DeTure, Shunsuke Koga, Neill R Graff-Radford, Bradley F Boeve, Keith A. Josephs, Ronald C Petersen, Jennifer Whitwell, Ranjan Duara, Kelly E Lyons, Rajesh Pahwa, Lea T. Grinberg, William W. Seeley, Bruce Miller, Athena Schlereth, Salvatore Spina, David J Irwin, David A Wolk, EunRan Suh, Vivianna M Van Deerlin, Edward B Lee, Matthew P. Frosch, Theresa R. Connors, Derek H. Oakley, Laura Molina-Porcel, Iban Aldecoa, Mircea Balasa, Sergi Borrego-Ecija, Raquel Sanchez-Valle, Jordi Gascón‐Bayarri, Pilar Sanz-Cartagena, Gerard Piñol‐Ripoll, Rosa Maria de Eugenio Huélamo, Ellen Gelpí, Tamar Gefen, Rudolph J Castellani, Margaret E. Flanagan, Emily Rogalskı, Sandra Weıntraub, Julie A. Schneider, Kevin F Bieniek, Xiongwei Zhu, Javier Redding-Ochoa, Koping Chang, Juan C. Troncoso, Stefan Prokop, Bernardino Ghetti, Kathy L. Newell, Max Jacobsen, Andrew Robinson, Federico Roncaroli, Christopher Kobylecki, Matthew Jones, Anna Richardson, Julie Snowden, James B. Rowe, Annelies Quaegebeur, Kieren Allinson, Thomas G Beach, Geidy E. Serrano, Andrew F Teich, Xena Flowers, Allison C Heaps, Sandra Leskinen, Julia Keith, Sandra E. Black, Mario Masellis, Andrew King, Safa-Al Sarraj, Claire Troakes, Glenda M. Halliday, John R. Hodges, Jillian J. Kril, John B. Kwok, Olivier Piguet, Marla Gearing |
| Journal | Brain communications |
| Year | 2026 |
| DOI |
10.1093/braincomms/fcag266
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.